Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Spotlight on fibrinogen antagonists

Sep. 2, 1997

TNK-tPA as effective as tPA, studies show

Aug. 27, 1997

PRISM-PLUS results on tirofiban released

Aug. 27, 1997

Initial PURSUIT trial results presented in Stockholm

Aug. 25, 1997

Lovenox superiority established in ESSENCE trial

Aug. 21, 1997

Fibrinogen antagonists from Yamanouchi

Aug. 20, 1997

Stanford announces three studies on leg ischemia treatments

Aug. 20, 1997

Glaxo Wellcome discloses a new series of thrombin inhibitors

Aug. 18, 1997

Arginine mimetics from Boehringer Mannheim

Aug. 13, 1997

Normiflo launched in U.S.

Aug. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...